Cipher Pharmaceuticals Inc. (TSE:CPH - Get Free Report) NASDAQ: CPHR shares crossed below its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of C$12.81 and traded as low as C$12.81. Cipher Pharmaceuticals shares last traded at C$12.86, with a volume of 23,771 shares traded.
Wall Street Analysts Forecast Growth
Separately, Canaccord Genuity Group set a C$12.50 target price on Cipher Pharmaceuticals and gave the company a "hold" rating in a research note on Monday, April 7th.
Get Our Latest Report on Cipher Pharmaceuticals
Cipher Pharmaceuticals Stock Performance
The company has a market capitalization of C$230.88 million, a PE ratio of 14.20 and a beta of 1.20. The stock's fifty day simple moving average is C$12.81 and its 200-day simple moving average is C$13.01. The company has a debt-to-equity ratio of 41.22, a quick ratio of 2.67 and a current ratio of 2.00.
Cipher Pharmaceuticals Company Profile
(
Get Free Report)
Cipher Pharmaceuticals Inc is a specialty pharmaceutical company. Its products include Dermatology Products, Hospital Acute Care Products, and Out-Licensed Products among others. The company's geographical segments include Canada and the United States.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Cipher Pharmaceuticals, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cipher Pharmaceuticals wasn't on the list.
While Cipher Pharmaceuticals currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
